Pomegranate Consumption by Poly-medicated Metabolic Syndrome Patients
Effect of a Pomegranate Extract on Metabolic and Inflammatory Markers, and the Gut Microbiota of Poly-medicated Metabolic Syndrome Patients
Sponsor: Hospital General Universitario Reina Sofía de Murcia
This NA trial investigates Metabolic Syndrome and is currently completed. Hospital General Universitario Reina Sofía de Murcia leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Oct 2020 — Jan 2021 [monthly]
Completed NA
-
Apr 2020 — Oct 2020 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 2 earlier versions
-
Oct 2019 — Apr 2020 [monthly]
Active Not Recruiting NA
-
Sep 2019 — Oct 2019 [monthly]
Active Not Recruiting NA
First recorded
Jun 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hospital General Universitario Reina Sofía de Murcia
- National Research Council, Spain
For direct contact, visit the study record on ClinicalTrials.gov .